Asset
ENOBLITUZUMAB
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01391143 | phase1 | completed | 2011-07-01 | 2019-04-18 | MacroGenics | Safety Study of MGA271 in Refractory Cancer |
| NCT01918930 | phase1 | terminated | 2013-07-01 | 2016-10-01 | MacroGenics | Tissue Procurement Substudy for Participants in Study CP-MGA271-01 |
FDA applications (0)
This company has no applications containing this asset.